The AJMC® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.
The Utilization of Combination Therapy in Patients with Diabetes
Key opinion leaders discuss the role of combination therapies in the management of diabetes.
Managing Blood Pressure in Patients With Diabetes
Managing hypertension is a critical aspect of diabetes disease management.
Secondary ADAPT Analysis Shows HRQOL Benefit of Efgartigimod in Myasthenia Gravis
Data from the secondary analysis show that the improvements seen in health-related quality of life (HRQOL) translated into clinical improvements.
Case Report Highlights Rare Case of CML Presenting With Morel Lavallée Lesion
The case is believed to be just the second reported in the scientific literature.
Nusinersen Treatment Had Positive Effect in Patients With SMA
Pediatric and adult patients with a diagnosis of spinal muscular atrophy (SMA) benefitted from nusinersen treatment in that they were able to prolong their walking time.
Investigators Find Potential Biomarker for Platinum-Based Chemotherapy Response in NSCLC
Patients who had non–small cell lung cancer (NSCLC) with homologous recombination gene mutations had better outcomes, although no single gene in the pathway appeared to have a causal role.
Insurance Authorization Considerations Associated With Rett Syndrome Treatment
Considerations for insurance preauthorization and reauthorization are explored by a key opinion leader.
Treatment Burden Associated with Rett Syndrome
Patients and families facing a Rett syndrome diagnosis experience an array of burdens.
Key Contributors to Long-term Outcomes for Patients With MDD
Drs Chitre and Weaver share their finals thoughts, highlighting key contributors to long-term outcomes for patients with major depressive disorder.
The Impact of Early Effective Treatment in MDD
Early effective treatment strategies can have a significant impact on long-term effects for patients with MDD.
Immune Profiling Study Offers Potential New Patient-Stratification Tools in Glioblastoma
The findings include the identification of a 12-gene signature that could be used to categorize patients as high or low risk.
COVID-19 May Accelerate Onset of Myasthenia Gravis, Case Study Suggests
The researchers hypothesize that SARS-CoV-2 infection may have triggered thymic inflammation, spearheading initial expression of muscle-like epitopes and T-cell dysregulation.
Concurrent Antibiotics, Steroids Raise CDI Risk in People With Lung Cancer Receiving EGFR-TKIs
The new report found no evidence that second-generation tyrosine kinase inhibitors (TKIs) were more likely to lead to Clostridioides difficile infection (CDI) in patients with lung cancer.
How CAR T Therapies Stack Up Against Standard of Care for LBCL Across Lines of Treatment, Cost Perspectives
During 2022, the FDA approved 2 chimeric antigen receptor (CAR) T-cell therapies for use in second-line treatment, offering new treatment choices but raising the question: What options remain once a patient relapses after CAR T?
Interleukin-13, Periostin Show Potential as Biomarkers in Prurigo Nodularis
Levels of certain biomarkers of inflammation in prurigo nodularis were evaluated between patients with and without the chronic inflammatory skin disorder, with the goal of showing potential for precision medicine in prurigo nodularis.
Impact of Patient Factors on Developing AML After MDS or CML; Ponatinib in Highly Resistant CP-CML
Research presented at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition examined how certain patient and demographic characteristics that may be related to socioeconomic disparities impact the risk of hematological cancers; the influence of diabetes on chronic myeloid leukemia; and 2 updates on ponatinib.
Lifestyle Intervention May Help Reduce T2D Risk in Women With Prior Gestational Diabetes
A review showed lifestyle intervention was linked to a 24% reduction in type 2 diabetes (T2D) incidence among women with prior gestational diabetes, compared with standard of care.
Experts Issue Caution for Evolocumab Following New Review of FOURIER Data; Amgen Disputes the Claims
Investigators writing in BMJ Open called for “a complete restoration of FOURIER trial data.” Amgen, the maker of evolocumab, said it stood by the data.
Administering Antimicrobial Therapy Before CIT May Be Safer Option in NSCLC
This study investigated the effects of antimicrobial therapy among patients with non–small cell lung cancer (NSCLC) who received immunotherapy with a checkpoint inhibitor or chemotherapy plus immunotherapy (CIT).
Treatment Strategies for Hyperglycemia
The panel shares insights into the evolution of treatment strategies for patients with diabetes.
Insurance Considerations in Diabetes Management
A panel of experts discuss considerations in insurance coverage for the treatment of patients with diabetes.
Patient Frailty Impacting Multiple Myeloma (MM) Treatment Strategies
Brea C. Lipe, MD, highlights considerations for frail patients when treating for MM.
SWOG777 Trial and DRd vs VRd
Medical experts explore the SWOG-S0777 trial and present an overview of daratumumab in combination with lenalidomide and dexamethasone (DRd) vs bortezomib, lenalidomide, and low-dose dexamethasone (VRd).
Patient Education and Proper Inhaler Technique
Inhaler technique informs health care outcomes in COPD management and should be a primary focus in patient education priorities.
Optimal Management of COPD: Escalation and De-escalation of Therapy
Treatment pathways, including escalation and de-escalation of therapy, for patients with COPD are explored by a panel of medical experts.
Rett Syndrome: The Diagnostic Journey (Part 2)
Patient advocate Paige Nues elaborates on the patient journey associated with a Rett syndrome diagnosis.
Rett Syndrome: The Diagnostic Journey (Part 1)
Paige Nues, from the International Rett Syndrome Foundation, provides insights on the diagnostic journey for patients with Rett syndrome.
Aligning MDD Treatment Goals for Payers and Patients
Drs Weaver and Chitre discuss aligning key considerations for payers and goals of therapy for patients in the treatment of MDD.
Supporting Adherence for Patients with MDD
Drs Weaver and Chitre share strategies to support MDD treatment adherence across their patient populations.
Dr Hossein Kazemi: What Patients With MM Consider When Stopping Therapy
M. Hossein Kazemi, MD, medical oncologist and hematologist, Astera Cancer Care, discusses the benefits of de-escalating treatment for patients with multiple myeloma.
2 Clarke Drive Cranbury, NJ 08512